首页 > 最新文献

Journal of Skin Cancer最新文献

英文 中文
Vitamin D and Vitamin D Analogs as Adjuncts to Field Therapy Treatments for Actinic Keratoses: Current Research and Future Approaches. 维生素D和维生素D类似物作为光化性角化病现场治疗的辅助药物:目前的研究和未来的方法。
IF 1.1 Q3 DERMATOLOGY Pub Date : 2021-06-19 eCollection Date: 2021-01-01 DOI: 10.1155/2021/9920558
Zafer Sattouf, Steven J Repas, Jeffrey B Travers, Craig A Rohan

Actinic keratoses (AK), also known as solar keratoses, are precancerous hyperkeratotic papules caused by long-term exposure to ultraviolet radiation. Management of AK prior to progression to cutaneous malignancy represents an important window of intervention. This is important on a population level, given the high incidence, morbidity, financial costs, and the low but measurable risk of mortality from cutaneous neoplasia. Treatments for AK have been refined for many years with significant progress over the past decade. Those recent advancements lead to questions about current treatment paradigms and the role of harnessing the immune system in field therapies. Recent studies suggest a key interplay between vitamin D and cancer immunity; in particular, the systemic and/or topical vitamin D analogs can augment field therapies used for severe actinic damage. In this review, we will examine the literature supporting the use of vitamin D-directed therapies to improve field therapy approaches. An enhanced understanding of these recent concepts with a focus on mechanisms is important in the optimized management of AK. These mechanisms will be critical in guiding whether selected populations, including those with immunosuppression, heritable cancer syndromes, and other risk factors for skin cancer, can benefit from these new concepts with vitamin D analogs and whether the approaches will be as effective in these populations as in immunocompetent patients.

光化性角化病(AK),也被称为太阳角化病,是由于长期暴露于紫外线辐射而引起的癌前角化性丘疹。在进展为皮肤恶性肿瘤之前对AK的管理是一个重要的干预窗口。考虑到皮肤肿瘤的高发病率、高发病率、高经济成本和低但可测量的死亡率风险,这在人群水平上是很重要的。治疗AK已经改进了许多年,在过去的十年中取得了重大进展。这些最近的进展引发了对当前治疗模式和利用免疫系统在现场治疗中的作用的质疑。最近的研究表明,维生素D与癌症免疫之间存在关键的相互作用;特别是,全身和/或局部维生素D类似物可以增强用于严重光化损伤的现场治疗。在这篇综述中,我们将研究支持使用维生素d定向治疗来改善现场治疗方法的文献。加强对这些最新概念的理解,关注机制,对AK的优化管理是重要的。这些机制对于指导特定人群,包括那些具有免疫抑制、遗传性癌症综合征和其他皮肤癌危险因素的人群,是否可以从维生素D类似物的这些新概念中受益,以及这些方法是否在这些人群中与在免疫功能正常的患者中一样有效至关重要。
{"title":"Vitamin D and Vitamin D Analogs as Adjuncts to Field Therapy Treatments for Actinic Keratoses: Current Research and Future Approaches.","authors":"Zafer Sattouf,&nbsp;Steven J Repas,&nbsp;Jeffrey B Travers,&nbsp;Craig A Rohan","doi":"10.1155/2021/9920558","DOIUrl":"https://doi.org/10.1155/2021/9920558","url":null,"abstract":"<p><p>Actinic keratoses (AK), also known as solar keratoses, are precancerous hyperkeratotic papules caused by long-term exposure to ultraviolet radiation. Management of AK prior to progression to cutaneous malignancy represents an important window of intervention. This is important on a population level, given the high incidence, morbidity, financial costs, and the low but measurable risk of mortality from cutaneous neoplasia. Treatments for AK have been refined for many years with significant progress over the past decade. Those recent advancements lead to questions about current treatment paradigms and the role of harnessing the immune system in field therapies. Recent studies suggest a key interplay between vitamin D and cancer immunity; in particular, the systemic and/or topical vitamin D analogs can augment field therapies used for severe actinic damage. In this review, we will examine the literature supporting the use of vitamin D-directed therapies to improve field therapy approaches. An enhanced understanding of these recent concepts with a focus on mechanisms is important in the optimized management of AK. These mechanisms will be critical in guiding whether selected populations, including those with immunosuppression, heritable cancer syndromes, and other risk factors for skin cancer, can benefit from these new concepts with vitamin D analogs and whether the approaches will be as effective in these populations as in immunocompetent patients.</p>","PeriodicalId":17172,"journal":{"name":"Journal of Skin Cancer","volume":"2021 ","pages":"9920558"},"PeriodicalIF":1.1,"publicationDate":"2021-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8249223/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39220539","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of the Effect of Alpha and Hydrocortisone Ointments on Prevention of Acute Skin Complications Due to Radiotherapy in Breast Cancer Patients. α软膏与氢化可的松软膏预防乳腺癌放疗急性皮肤并发症的疗效比较。
IF 1.1 Q3 DERMATOLOGY Pub Date : 2021-06-16 eCollection Date: 2021-01-01 DOI: 10.1155/2021/5575688
Mansour Rezaei, Ahmad Khoshay, Nasrin Amirifard, Ali Goli, Alireza Abdi

Background: Radiotherapy in breast cancer patients is associated with acute and delayed side effects. This study aimed to compare the effect of alpha and hydrocortisone 1% (H1%) ointments on prevention of acute skin complications due to radiotherapy in breast cancer patients.

Methods: This clinical trial was conducted on 86 patients with breast cancer in the radiotherapy center of Imam Reza Hospital of Kermanshah, Iran. Using the records, the patients were selected and randomly divided into alpha and H1% groups after obtaining informed consent. The severity of dermatitis, complications, and patient complaints during treatment were evaluated weekly for up to 6 weeks by RTOG criteria. Data were analyzed using SPSS-16 software.

Results: At the end of the third, fourth, fifth, and sixth weeks, 10 (11.7%), 25 (29.1%), 53 (61.6%), and 28 (32.6%) patients had skin complications, respectively. In weeks 5 and 6 in the H1 group, the incidence of complications was higher (P = 0.001). The frequency of pain and burning complaints at the end of the third, fourth, fifth, and sixth weeks was 15 (17.4%), 37 (43.0%), 52 (60.5%), and 1(1.2%), respectively. Pain and burning intensity in the fourth and fifth weeks in the H1 group was lower than alpha (P = 0010). Complaints of skin itching at the end of the third, fourth, and fifth weeks were 16 (18.6%), 25 (29.1%), and 28 (32.6), respectively. This complication was lower in the H1% group during these weeks (P < 0.05).

Conclusion: Alpha ointment is more effective than H1% in relieving pain and burning, preventing complications except itching. It seems using an alpha ointment or combining it with H1% is an appropriate strategy to reduce the rate of injuries and skin complications of radiotherapy.

背景:乳腺癌患者的放疗与急性和迟发性副作用相关。本研究旨在比较α软膏和1%氢化可的松软膏预防乳腺癌患者放疗后急性皮肤并发症的效果。方法:对伊朗克尔曼沙阿伊玛目礼萨医院放疗中心86例乳腺癌患者进行临床试验。根据病历选择患者,经知情同意后随机分为α组和H1%组。根据RTOG标准,每周评估治疗期间皮炎、并发症和患者主诉的严重程度,持续6周。采用SPSS-16软件对数据进行分析。结果:第3、4、5、6周时,皮肤并发症患者分别为10例(11.7%)、25例(29.1%)、53例(61.6%)、28例(32.6%)。在第5周和第6周,H1组并发症发生率较高(P = 0.001)。第3、4、5、6周末出现疼痛和灼烧的频率分别为15例(17.4%)、37例(43.0%)、52例(60.5%)和1例(1.2%)。H1组第4、5周疼痛和灼烧强度均低于α组(P = 0010)。在第三、第四和第五周结束时,皮肤瘙痒的主诉分别为16例(18.6%)、25例(29.1%)和28例(32.6)。结论:α软膏在缓解疼痛和灼烧、预防除瘙痒外的并发症方面比H1%组更有效。似乎使用α软膏或与H1%联合使用是一种适当的策略,以减少放射治疗的损伤率和皮肤并发症。
{"title":"Comparison of the Effect of Alpha and Hydrocortisone Ointments on Prevention of Acute Skin Complications Due to Radiotherapy in Breast Cancer Patients.","authors":"Mansour Rezaei,&nbsp;Ahmad Khoshay,&nbsp;Nasrin Amirifard,&nbsp;Ali Goli,&nbsp;Alireza Abdi","doi":"10.1155/2021/5575688","DOIUrl":"https://doi.org/10.1155/2021/5575688","url":null,"abstract":"<p><strong>Background: </strong>Radiotherapy in breast cancer patients is associated with acute and delayed side effects. This study aimed to compare the effect of alpha and hydrocortisone 1% (H1%) ointments on prevention of acute skin complications due to radiotherapy in breast cancer patients.</p><p><strong>Methods: </strong>This clinical trial was conducted on 86 patients with breast cancer in the radiotherapy center of Imam Reza Hospital of Kermanshah, Iran. Using the records, the patients were selected and randomly divided into alpha and H1% groups after obtaining informed consent. The severity of dermatitis, complications, and patient complaints during treatment were evaluated weekly for up to 6 weeks by RTOG criteria. Data were analyzed using SPSS-16 software.</p><p><strong>Results: </strong>At the end of the third, fourth, fifth, and sixth weeks, 10 (11.7%), 25 (29.1%), 53 (61.6%), and 28 (32.6%) patients had skin complications, respectively. In weeks 5 and 6 in the H1 group, the incidence of complications was higher (<i>P</i> = 0.001). The frequency of pain and burning complaints at the end of the third, fourth, fifth, and sixth weeks was 15 (17.4%), 37 (43.0%), 52 (60.5%), and 1(1.2%), respectively. Pain and burning intensity in the fourth and fifth weeks in the H1 group was lower than alpha (<i>P</i> = 0010). Complaints of skin itching at the end of the third, fourth, and fifth weeks were 16 (18.6%), 25 (29.1%), and 28 (32.6), respectively. This complication was lower in the H1% group during these weeks (<i>P</i> < 0.05).</p><p><strong>Conclusion: </strong>Alpha ointment is more effective than H1% in relieving pain and burning, preventing complications except itching. It seems using an alpha ointment or combining it with H1% is an appropriate strategy to reduce the rate of injuries and skin complications of radiotherapy.</p>","PeriodicalId":17172,"journal":{"name":"Journal of Skin Cancer","volume":"2021 ","pages":"5575688"},"PeriodicalIF":1.1,"publicationDate":"2021-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221894/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39081948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Keratinocyte Skin Cancers in General Surgery: The Impact of Anaesthesia, Trainee Supervision, and Choice of Reconstruction. 角化细胞皮肤癌在普通外科:麻醉的影响,学员的监督,和选择重建。
IF 1.1 Q3 DERMATOLOGY Pub Date : 2021-04-13 eCollection Date: 2021-01-01 DOI: 10.1155/2021/5537273
William McSweeney, Matthew Leaning, Darius Dastouri

Background: Keratinocyte skin cancers are common in Australia, incurring disproportionately high health expenditure in comparison with mortality. General surgeons often excise these lesions as day-surgery. Balancing individual complexities of these cancers with trainee supervision and health expenditure is key to deliver efficacious care and maintain day-surgery volume for patients during a pandemic.

Methods: A retrospective, cross-sectional study was performed, examining 414 procedures from January 2019 to December 2020. Pathology was reviewed, and benign lesions excluded. Complete excision was based on 5 mm margins for squamous cell carcinoma (SCC), 0.5 mm microscopic margins for low-risk basal cell carcinoma (BCC) subtypes, and 3 mm for high-risk. Results of trainee-performed local anesthetic (LA) excision and general anesthetic (GA) excision (consultant scrubbed) were compared.

Results: 288 excisions were reviewed for completeness, location, and reconstruction modality. 69% were BCC (199), and 31% were SCC (89). These were excised under GA (72.5%) and LA (27.5%). 25.6% of BCC excisions were "close," and 22.6% were "positive" under GA, whilst 31% were "close" and 15.5% were "positive" under LA. 52.8% of SCC excisions were "close," and 7.8% were "positive" under GA, compared with 42.8% "close" and 9.5% "positive" under LA. Complex reconstruction (skin graft, flap) was more common under GA (38% SCC and 36.1% BCC), but occurred at a modest rate under LA (22% BCC and 28.5% SCC).

Conclusions: The results confirm that comparable margins and reconstruction options are achievable when excising keratinocyte cancers under LA by surgical trainees. This is fundamental in cost and timesaving, as well as reducing risk of aerosolisation of virus during GA, in a pandemic.

背景:角化细胞皮肤癌在澳大利亚很常见,与死亡率相比,造成了不成比例的高卫生支出。普通外科医生经常在日间手术中切除这些病变。在这些癌症的个体复杂性与学员监督和卫生支出之间取得平衡,是在大流行期间为患者提供有效护理和维持日间手术量的关键。方法:对2019年1月至2020年12月期间的414例手术进行回顾性横断面研究。病理检查,并排除良性病变。完全切除基于鳞状细胞癌(SCC)的5毫米边缘,低风险基底细胞癌(BCC)亚型的0.5毫米显微镜边缘,高风险的3毫米边缘。比较实习生行局麻(LA)切除与全麻(GA)切除(会诊医生擦洗)的结果。结果:对288例切除手术的完整性、位置和重建方式进行了回顾。69%为BCC(199例),31%为SCC(89例)。在GA(72.5%)和LA(27.5%)下切除。在GA下,25.6%的BCC切除“接近”,22.6%为“阳性”,而在LA下,31%为“接近”,15.5%为“阳性”。在GA下,52.8%的SCC切除“接近”,7.8%为“阳性”,而在LA下,42.8%为“接近”,9.5%为“阳性”。复杂重建(皮肤移植,皮瓣)在GA (38% SCC和36.1% BCC)下更为常见,但在LA (22% BCC和28.5% SCC)下发生率适中。结论:结果证实,在LA下由外科实习生切除角化细胞癌时,可实现相当的边缘和重建选择。这对于节省成本和时间,以及在大流行期间减少病毒雾化的风险至关重要。
{"title":"Keratinocyte Skin Cancers in General Surgery: The Impact of Anaesthesia, Trainee Supervision, and Choice of Reconstruction.","authors":"William McSweeney,&nbsp;Matthew Leaning,&nbsp;Darius Dastouri","doi":"10.1155/2021/5537273","DOIUrl":"https://doi.org/10.1155/2021/5537273","url":null,"abstract":"<p><strong>Background: </strong>Keratinocyte skin cancers are common in Australia, incurring disproportionately high health expenditure in comparison with mortality. General surgeons often excise these lesions as day-surgery. Balancing individual complexities of these cancers with trainee supervision and health expenditure is key to deliver efficacious care and maintain day-surgery volume for patients during a pandemic.</p><p><strong>Methods: </strong>A retrospective, cross-sectional study was performed, examining 414 procedures from January 2019 to December 2020. Pathology was reviewed, and benign lesions excluded. Complete excision was based on 5 mm margins for squamous cell carcinoma (SCC), 0.5 mm microscopic margins for low-risk basal cell carcinoma (BCC) subtypes, and 3 mm for high-risk. Results of trainee-performed local anesthetic (LA) excision and general anesthetic (GA) excision (consultant scrubbed) were compared.</p><p><strong>Results: </strong>288 excisions were reviewed for completeness, location, and reconstruction modality. 69% were BCC (199), and 31% were SCC (89). These were excised under GA (72.5%) and LA (27.5%). 25.6% of BCC excisions were \"close,\" and 22.6% were \"positive\" under GA, whilst 31% were \"close\" and 15.5% were \"positive\" under LA. 52.8% of SCC excisions were \"close,\" and 7.8% were \"positive\" under GA, compared with 42.8% \"close\" and 9.5% \"positive\" under LA. Complex reconstruction (skin graft, flap) was more common under GA (38% SCC and 36.1% BCC), but occurred at a modest rate under LA (22% BCC and 28.5% SCC).</p><p><strong>Conclusions: </strong>The results confirm that comparable margins and reconstruction options are achievable when excising keratinocyte cancers under LA by surgical trainees. This is fundamental in cost and timesaving, as well as reducing risk of aerosolisation of virus during GA, in a pandemic.</p>","PeriodicalId":17172,"journal":{"name":"Journal of Skin Cancer","volume":"2021 ","pages":"5537273"},"PeriodicalIF":1.1,"publicationDate":"2021-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8057899/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38954424","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effectiveness of Sun Protection Interventions Delivered to Adolescents in a Secondary School Setting: A Systematic Review. 对中学青少年防晒干预措施的有效性:一项系统综述。
IF 1.1 Q3 DERMATOLOGY Pub Date : 2021-03-04 eCollection Date: 2021-01-01 DOI: 10.1155/2021/6625761
Bronwen M McNoe, Kate C Morgaine, Anthony I Reeder

Aim: The aim of this systematic review is to summarise the evidence of the effectiveness of interventions targeted to adolescents (13 to 18 years inclusive) and delivered in a secondary school setting with the purpose of improving sun protection behaviour, reducing ultraviolet radiation (UVR) exposure, and/or improving physiological outcomes related to UVR exposure (such as erythema or naevi development).

Methods: Peer-reviewed journal articles were identified from seven database searches (Cochrane, Embase, CINAHL, Scopus, Medline, PsycInfo, and Web of Science) to January 2020, forward citation searches of relevant articles, and monitoring of WHO INTERSUN UVR list server for recent publications. Relevant articles were collected and critically analysed using the Effective Public Health Practice framework. Two reviewers independently reviewed, and when deemed eligible, extracted data and performed quality appraisals for each study.

Results: Thirteen studies met the criteria for inclusion in the review. There were no studies that met a "strong" quality rating, five received a "moderate" quality rating, and eight studies a "weak" quality rating. Three of those with a moderate rating found evidence for effectiveness. The most promising interventions overall (including the pilot/uncontrolled studies) were those that moved beyond a pure health education approach and used innovative approaches such as the provision of shade, or use of technology (e.g., appearance-based apps or real-time ultraviolet index (UVI) monitors).

Conclusions: There is a lack of high-quality published studies investigating the interventions delivered in a secondary school setting to protect students from UVR. The evidence could be strengthened if researchers used consistent, standardised outcome measures for sun protection exposure and behaviour. Other factors limiting the strength of evidence were short follow-up times (largely less than 6 months) and/or nonrobust study design.

目的:本系统综述的目的是总结针对青少年(13至18岁)的干预措施的有效性证据,并在中学环境中提供干预措施,以改善防晒行为,减少紫外线辐射(UVR)暴露,和/或改善与UVR暴露相关的生理结果(如红斑或痣发展)。方法:从截至2020年1月的7个数据库检索(Cochrane、Embase、CINAHL、Scopus、Medline、PsycInfo和Web of Science)中识别同行评议的期刊文章,转发相关文章的引文检索,并监测WHO INTERSUN UVR列表服务器上的最新出版物。收集了相关文章,并使用有效公共卫生实践框架进行了批判性分析。两名审稿人独立审查,当认为符合条件时,提取数据并对每个研究进行质量评估。结果:13项研究符合纳入本综述的标准。没有研究达到“强”质量等级,5个研究达到“中等”质量等级,8个研究达到“弱”质量等级。其中三个中等等级的人发现了有效的证据。总体而言,最有希望的干预措施(包括试点/非对照研究)是那些超越纯粹的健康教育方法并使用创新方法的干预措施,如提供遮阳或使用技术(例如,基于外观的应用程序或实时紫外线指数(UVI)监视器)。结论:缺乏高质量的已发表研究,调查在中学环境中提供的保护学生免受紫外线辐射的干预措施。如果研究人员对防晒暴露和行为使用一致的、标准化的结果测量方法,证据可能会得到加强。其他限制证据强度的因素是随访时间短(大部分少于6个月)和/或研究设计不稳健。
{"title":"Effectiveness of Sun Protection Interventions Delivered to Adolescents in a Secondary School Setting: A Systematic Review.","authors":"Bronwen M McNoe,&nbsp;Kate C Morgaine,&nbsp;Anthony I Reeder","doi":"10.1155/2021/6625761","DOIUrl":"https://doi.org/10.1155/2021/6625761","url":null,"abstract":"<p><strong>Aim: </strong>The aim of this systematic review is to summarise the evidence of the effectiveness of interventions targeted to adolescents (13 to 18 years inclusive) and delivered in a secondary school setting with the purpose of improving sun protection behaviour, reducing ultraviolet radiation (UVR) exposure, and/or improving physiological outcomes related to UVR exposure (such as erythema or naevi development).</p><p><strong>Methods: </strong>Peer-reviewed journal articles were identified from seven database searches (Cochrane, Embase, CINAHL, Scopus, Medline, PsycInfo, and Web of Science) to January 2020, forward citation searches of relevant articles, and monitoring of WHO INTERSUN UVR list server for recent publications. Relevant articles were collected and critically analysed using the Effective Public Health Practice framework. Two reviewers independently reviewed, and when deemed eligible, extracted data and performed quality appraisals for each study.</p><p><strong>Results: </strong>Thirteen studies met the criteria for inclusion in the review. There were no studies that met a \"strong\" quality rating, five received a \"moderate\" quality rating, and eight studies a \"weak\" quality rating. Three of those with a moderate rating found evidence for effectiveness. The most promising interventions overall (including the pilot/uncontrolled studies) were those that moved beyond a pure health education approach and used innovative approaches such as the provision of shade, or use of technology (e.g., appearance-based apps or real-time ultraviolet index (UVI) monitors).</p><p><strong>Conclusions: </strong>There is a lack of high-quality published studies investigating the interventions delivered in a secondary school setting to protect students from UVR. The evidence could be strengthened if researchers used consistent, standardised outcome measures for sun protection exposure and behaviour. Other factors limiting the strength of evidence were short follow-up times (largely less than 6 months) and/or nonrobust study design.</p>","PeriodicalId":17172,"journal":{"name":"Journal of Skin Cancer","volume":"2021 ","pages":"6625761"},"PeriodicalIF":1.1,"publicationDate":"2021-03-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7952177/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"25501175","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Inguinal Lymph Node Dissection for Advanced Stages of Plantar Melanoma in a Low-Income Country. 腹股沟淋巴结清扫晚期足底黑色素瘤在低收入国家。
IF 1.1 Q3 DERMATOLOGY Pub Date : 2020-12-11 eCollection Date: 2020-01-01 DOI: 10.1155/2020/8854460
Ollo Roland Somé, Malick Diallo, Damien Konkobo, Nassirou Yabré, Valentin Konségré, Issouf Konaté, Sidy Ka

Background: Advanced stages of plantar acral lentiginous melanoma are common in Africa. Inguinal lymph node dissection (ILND) in these cases plays a critical role in disease-free and overall survival. Our study aims to share our experience in ILND for advanced plantar melanomas. Methods and Study Design. Four-year prospective study. Patients. We included all documented cases of advanced stage plantar melanoma with clinically detectable inguinal lymph node metastasis. Twenty-two of 27 patients identified-with mean age 56 years-underwent ILND. Studied Variables. Tumor patterns and stage, surgery, morbidity, oncologic pathology, and evolution were studied. Statistical software assessed the overall survival (OS).

Results: Plantar lesions were all excised with a cancer-free margin (3 cm). ILND was performed for 22 patients with visible (n = 11), palpable (n = 7), and ulcerous (n = 4) lymphadenopathies. It was performed through an S-shaped (n = 11) or ellipse-shaped skin incision (n = 11). The tumors were AJCC stage III (n = 18) and IV (n = 2). We found high Breslow index tumor thickness (>3 mm) and an advanced Clark IV stage (n = 20). All operative wounds healed within 46 days (21-90). Wound healing was delayed by suture failure (n = 16), lymphorrhoea (n = 22), and infection (n = 18). After 29 months, three patients had complete remissions, seven had recurrences, and twelve patients had died. The overall survival (OS) at one year was 56%. In two patients with AJCC stage III disease, the OS was better (22 months).

Conclusion: In low-income countries, ILND in advanced stages of plantar foot melanoma is a valuable surgical treatment option. Alongside ILND adjuvants, treatment must be available and accessible to improve survival.

背景:晚期足底肢端黄斑性黑色素瘤在非洲很常见。在这些病例中,腹股沟淋巴结清扫(ILND)在无病和总生存中起着至关重要的作用。我们的研究旨在分享我们在晚期足底黑色素瘤的ILND治疗中的经验。方法与研究设计。四年前瞻性研究。病人。我们纳入了所有临床可检测到腹股沟淋巴结转移的晚期足底黑色素瘤病例。27例患者中有22例(平均年龄56岁)接受了ILND。研究变量。研究了肿瘤的类型和分期、手术、发病率、肿瘤病理和演变。统计学软件评估总生存期(OS)。结果:足底病变全部切除,无癌边缘(3cm)。22例可见(n = 11)、可触及(n = 7)和溃疡性(n = 4)淋巴结病变患者进行了ILND。通过s形(n = 11)或椭圆形皮肤切口(n = 11)进行。肿瘤为AJCC III期(n = 18)和IV期(n = 2)。我们发现高Breslow指数肿瘤厚度(> 3mm)和晚期Clark IV期(n = 20)。所有手术创面均在46天(21 ~ 90天)内愈合。伤口愈合因缝合失败(16例)、淋巴漏(22例)和感染(18例)而延迟。29个月后,3例患者完全缓解,7例复发,12例死亡。1年总生存率(OS)为56%。在2例AJCC III期患者中,OS较好(22个月)。结论:在低收入国家,晚期足底黑色素瘤的ILND是一种有价值的手术治疗选择。除了ILND佐剂,治疗必须是可用的和可获得的,以提高生存率。
{"title":"Inguinal Lymph Node Dissection for Advanced Stages of Plantar Melanoma in a Low-Income Country.","authors":"Ollo Roland Somé,&nbsp;Malick Diallo,&nbsp;Damien Konkobo,&nbsp;Nassirou Yabré,&nbsp;Valentin Konségré,&nbsp;Issouf Konaté,&nbsp;Sidy Ka","doi":"10.1155/2020/8854460","DOIUrl":"https://doi.org/10.1155/2020/8854460","url":null,"abstract":"<p><strong>Background: </strong>Advanced stages of plantar acral lentiginous melanoma are common in Africa. Inguinal lymph node dissection (ILND) in these cases plays a critical role in disease-free and overall survival. Our study aims to share our experience in ILND for advanced plantar melanomas. <i>Methods and Study Design</i>. Four-year prospective study. <i>Patients</i>. We included all documented cases of advanced stage plantar melanoma with clinically detectable inguinal lymph node metastasis. Twenty-two of 27 patients identified-with mean age 56 years-underwent ILND. <i>Studied Variables.</i> Tumor patterns and stage, surgery, morbidity, oncologic pathology, and evolution were studied. Statistical software assessed the overall survival (OS).</p><p><strong>Results: </strong>Plantar lesions were all excised with a cancer-free margin (3 cm). ILND was performed for 22 patients with visible (<i>n</i> = 11), palpable (<i>n</i> = 7), and ulcerous (<i>n</i> = 4) lymphadenopathies. It was performed through an S-shaped (<i>n</i> = 11) or ellipse-shaped skin incision (<i>n</i> = 11). The tumors were AJCC stage III (<i>n</i> = 18) and IV (<i>n</i> = 2). We found high Breslow index tumor thickness (>3 mm) and an advanced Clark IV stage (<i>n</i> = 20). All operative wounds healed within 46 days (21-90). Wound healing was delayed by suture failure (<i>n</i> = 16), lymphorrhoea (<i>n</i> = 22), and infection (<i>n</i> = 18). After 29 months, three patients had complete remissions, seven had recurrences, and twelve patients had died. The overall survival (OS) at one year was 56%. In two patients with AJCC stage III disease, the OS was better (22 months).</p><p><strong>Conclusion: </strong>In low-income countries, ILND in advanced stages of plantar foot melanoma is a valuable surgical treatment option. Alongside ILND adjuvants, treatment must be available and accessible to improve survival.</p>","PeriodicalId":17172,"journal":{"name":"Journal of Skin Cancer","volume":"2020 ","pages":"8854460"},"PeriodicalIF":1.1,"publicationDate":"2020-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/8854460","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38767737","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of Treatment for Melanoma Brain Metastases. 黑素瘤脑转移的治疗结果。
IF 1.1 Q3 DERMATOLOGY Pub Date : 2020-11-05 eCollection Date: 2020-01-01 DOI: 10.1155/2020/7520924
Mantas Janavicius, Nadezda Lachej, Giedre Anglickiene, Ieva Vincerzevskiene, Birute Brasiuniene

Background: Historically, melanoma with brain metastases has a poor prognosis. In this retrospective medical record review, we report basic clinicopathological parameters and the outcomes of patients with melanoma and brain metastases treated with different treatment modalities before the era of immunotherapy and modern radiotherapy technique.

Methods: Patients with metastatic melanoma were treated with surgery, radiotherapy, and/or systemic therapy from 1998 to 2017. In our study, they were identified and stratified depending on treatment methods. Overall survival was defined as the time from the date of brain metastases to the death or last follow-up (2019 June 1st). Survival curves were estimated using the Kaplan-Meier method that was employed to calculate the hazard ratio.

Results: Six (12%) of 50 patients are still alive as of the last follow-up. The median overall survival from the onset of brain metastases was 11 months. The longest survival time was observed in patients treated by surgery followed by radiotherapy, surgery followed by radiotherapy and systemic therapy, and also radiotherapy followed by systemic therapy. The shortest survival was observed in the best supportive care group and patients treated by systemic therapy only.

Conclusions: Patients with brain metastases achieved better overall survival when treated by combined treatment modalities: surgery followed by radiotherapy (26.6 months overall survival), combining surgery, radiotherapy, and systemic therapy (18.7 months overall survival), and also radiotherapy followed by systemic therapy (13.8 months overall survival).

背景:从历史上看,伴有脑转移的黑色素瘤预后较差。在这篇回顾性的医疗记录回顾中,我们报告了在免疫治疗和现代放射治疗技术时代之前,黑色素瘤和脑转移患者接受不同治疗方式的基本临床病理参数和结果。方法:1998年至2017年,转移性黑色素瘤患者接受手术、放疗和/或全身治疗。在我们的研究中,根据治疗方法对它们进行了识别和分层。总生存期定义为从脑转移之日到死亡或最后一次随访(2019年6月1日)的时间。使用Kaplan-Meier方法估计生存曲线,该方法用于计算风险比。结果:截至最后一次随访,50例患者中有6例(12%)仍然存活。从脑转移开始的中位总生存期为11个月。手术后放疗、手术后放疗后全身治疗、放疗后全身治疗的患者生存时间最长。最佳支持治疗组和仅接受全身治疗的患者存活时间最短。结论:采用手术+放疗(26.6个月)、手术+放疗+全身治疗(18.7个月)、放疗+全身治疗(13.8个月)的联合治疗方式治疗脑转移患者获得了更好的总生存期。
{"title":"Outcomes of Treatment for Melanoma Brain Metastases.","authors":"Mantas Janavicius,&nbsp;Nadezda Lachej,&nbsp;Giedre Anglickiene,&nbsp;Ieva Vincerzevskiene,&nbsp;Birute Brasiuniene","doi":"10.1155/2020/7520924","DOIUrl":"https://doi.org/10.1155/2020/7520924","url":null,"abstract":"<p><strong>Background: </strong>Historically, melanoma with brain metastases has a poor prognosis. In this retrospective medical record review, we report basic clinicopathological parameters and the outcomes of patients with melanoma and brain metastases treated with different treatment modalities before the era of immunotherapy and modern radiotherapy technique.</p><p><strong>Methods: </strong>Patients with metastatic melanoma were treated with surgery, radiotherapy, and/or systemic therapy from 1998 to 2017. In our study, they were identified and stratified depending on treatment methods. Overall survival was defined as the time from the date of brain metastases to the death or last follow-up (2019 June 1<sup>st</sup>). Survival curves were estimated using the Kaplan-Meier method that was employed to calculate the hazard ratio.</p><p><strong>Results: </strong>Six (12%) of 50 patients are still alive as of the last follow-up. The median overall survival from the onset of brain metastases was 11 months. The longest survival time was observed in patients treated by surgery followed by radiotherapy, surgery followed by radiotherapy and systemic therapy, and also radiotherapy followed by systemic therapy. The shortest survival was observed in the best supportive care group and patients treated by systemic therapy only.</p><p><strong>Conclusions: </strong>Patients with brain metastases achieved better overall survival when treated by combined treatment modalities: surgery followed by radiotherapy (26.6 months overall survival), combining surgery, radiotherapy, and systemic therapy (18.7 months overall survival), and also radiotherapy followed by systemic therapy (13.8 months overall survival).</p>","PeriodicalId":17172,"journal":{"name":"Journal of Skin Cancer","volume":"2020 ","pages":"7520924"},"PeriodicalIF":1.1,"publicationDate":"2020-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/7520924","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38341019","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Histological Peripheral Margins and Recurrence of Melanoma In Situ Treated with Wide Local Excision. 广泛局部切除治疗原位黑色素瘤的组织学外周边缘和复发。
IF 1.1 Q3 DERMATOLOGY Pub Date : 2020-10-29 eCollection Date: 2020-01-01 DOI: 10.1155/2020/8813050
Francisco S Moura, Lucy E Homer, Stuart W McKirdy

Background: The incidence of melanoma in situ (MIS) is increasing faster compared to invasive melanoma. Despite varying international practice, a minimum of 5 mm surgical excision margin is currently recommended in the UK. There is no clear guidance on the minimum histological peripheral clearance margins.

Aim: This study compares the histological peripheral clearance margins of MIS using wide local excision (WLE) to the rate of recurrence and progression to invasive disease.

Methods: A retrospective single-center review was performed over a 5-year period. Inclusion criteria consisted of MIS diagnosis, ≥16 years of age, and treatment with WLE with curative intent. Those patients with a recurrence of a previous MIS or with a reported focus of invasion/regression were also included. Clinicopathological data and follow-up were recorded.

Results: 167 MIS were identified in 155 patients, 80% of which were lentigo maligna subtype. Of patients with completely excised MIS on histology (>0 mm), 9% had recurrence with a median time to recurrence of 36 months. Three (1.8%) cases recurred as invasive disease. Age, MIS site, MIS subtype, and histological evidence of foci of invasion/regression did not predict recurrence nor progression to invasive disease (p > 0.05). The recurrence rate of MIS with a histological excision margin ≤3.0 mm was 13% compared to 3% in those with histology margins of >3.0 mm (p=0.049).

Conclusion: A histological peripheral clearance of at least 3.0 mm is advocated to achieve lower recurrence rates. The follow-up duration should be reviewed due to the median recurrence occurring at 36 months in our cohort. Cumulative work on MIS needs to be collated and completed in a large multicenter study with a long follow-up period.

背景:与侵袭性黑色素瘤相比,原位黑色素瘤(MIS)的发病率增长更快。尽管国际惯例各不相同,英国目前推荐的最小手术切除量为5毫米。对于最小组织学外周清除率尚无明确的指导。目的:本研究比较采用大面积局部切除(WLE)的MIS的组织学外周清除率与复发和进展为侵袭性疾病的比率。方法:在5年的时间内进行回顾性单中心评价。纳入标准包括MIS诊断,年龄≥16岁,有治疗目的的WLE治疗。那些既往MIS复发或报道病灶浸润/消退的患者也包括在内。记录临床病理资料及随访。结果:155例患者共检出167例MIS,其中80%为lentigo恶性亚型。组织学上完全切除MIS (>0 mm)的患者中,9%复发,中位复发时间为36个月。3例(1.8%)复发为侵袭性疾病。年龄、MIS部位、MIS亚型和浸润/消退灶的组织学证据不能预测复发或进展为浸润性疾病(p > 0.05)。组织学切缘≤3.0 mm的MIS复发率为13%,而组织学切缘>3.0 mm的MIS复发率为3% (p=0.049)。结论:组织学外周清除至少3.0 mm可降低复发率。由于在我们的队列中复发的中位时间为36个月,随访时间应该进行审查。管理信息系统的累积工作需要在一个大型的多中心研究和长时间的随访中进行整理和完成。
{"title":"Histological Peripheral Margins and Recurrence of Melanoma In Situ Treated with Wide Local Excision.","authors":"Francisco S Moura,&nbsp;Lucy E Homer,&nbsp;Stuart W McKirdy","doi":"10.1155/2020/8813050","DOIUrl":"https://doi.org/10.1155/2020/8813050","url":null,"abstract":"<p><strong>Background: </strong>The incidence of melanoma in situ (MIS) is increasing faster compared to invasive melanoma. Despite varying international practice, a minimum of 5 mm surgical excision margin is currently recommended in the UK. There is no clear guidance on the minimum histological peripheral clearance margins.</p><p><strong>Aim: </strong>This study compares the histological peripheral clearance margins of MIS using wide local excision (WLE) to the rate of recurrence and progression to invasive disease.</p><p><strong>Methods: </strong>A retrospective single-center review was performed over a 5-year period. Inclusion criteria consisted of MIS diagnosis, ≥16 years of age, and treatment with WLE with curative intent. Those patients with a recurrence of a previous MIS or with a reported focus of invasion/regression were also included. Clinicopathological data and follow-up were recorded.</p><p><strong>Results: </strong>167 MIS were identified in 155 patients, 80% of which were lentigo maligna subtype. Of patients with completely excised MIS on histology (>0 mm), 9% had recurrence with a median time to recurrence of 36 months. Three (1.8%) cases recurred as invasive disease. Age, MIS site, MIS subtype, and histological evidence of foci of invasion/regression did not predict recurrence nor progression to invasive disease (<i>p</i> > 0.05). The recurrence rate of MIS with a histological excision margin ≤3.0 mm was 13% compared to 3% in those with histology margins of >3.0 mm (<i>p</i>=0.049).</p><p><strong>Conclusion: </strong>A histological peripheral clearance of at least 3.0 mm is advocated to achieve lower recurrence rates. The follow-up duration should be reviewed due to the median recurrence occurring at 36 months in our cohort. Cumulative work on MIS needs to be collated and completed in a large multicenter study with a long follow-up period.</p>","PeriodicalId":17172,"journal":{"name":"Journal of Skin Cancer","volume":"2020 ","pages":"8813050"},"PeriodicalIF":1.1,"publicationDate":"2020-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/8813050","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38591225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Comparative Analysis of Acral Melanoma in Chinese and Caucasian Patients. 中国人与白种人肢端黑色素瘤的比较分析。
IF 1.1 Q3 DERMATOLOGY Pub Date : 2020-10-06 eCollection Date: 2020-01-01 DOI: 10.1155/2020/5169051
Kai Huang, Yu Xu, Emmanuel M Gabriel, Subhasis Misra, Yong Chen, Sanjay P Bagaria

Background: Acral melanoma (AM) is a rare subtype of melanoma, which is one of the least common in Caucasian patients but is a common subtype of melanoma in Chinese patients. It is unclear if prognosis differs between Chinese and Caucasian patients diagnosed with AM. The aim of our study is to investigate patient characteristics and survival differences between Chinese and Caucasian AM patients.

Methods: Two large institutional melanoma databases from Fudan University Shanghai Cancer Center (FUSCC) and Mayo Clinic enterprise were retrospectively reviewed from 2009 to 2015. Clinicopathologic and survival data were collected and analyzed between the two groups. The primary outcome was disease-specific survival (DSS) and was calculated using the Kaplan Meier (KM) method.

Results: The Chinese group presented with more advanced disease compared with Caucasians: thicker Breslow depth (median 3.0 mm vs. 1.2 mm, p=0.003), more ulcerated disease (66.1% vs. 29%; p < 0.001), and advanced stages (stage II/III 84.3% vs. 37.1%; p < 0.001). No significant difference was identified in terms of age at diagnosis, location, histologic subtypes, or node positive rate. The 5-year DSS rate was 68.4% and 73% (p=0.56) in Chinese and Caucasians AM patients, respectively. Male gender, Breslow thickness, ulceration, and positive sentinel lymph nodes were independent poor prognostic factors on multivariate analysis.

Conclusions: There appears to be no difference in stage-stratified survival between Chinese and Caucasians, supporting the implementation of clinical trials for AM that could include both Chinese and Caucasian patients.

背景:肢端黑色素瘤(Acral melanoma, AM)是一种罕见的黑色素瘤亚型,是白人患者中最不常见的亚型之一,但在中国患者中是一种常见的黑色素瘤亚型。目前尚不清楚中国和高加索AM患者的预后是否不同。本研究的目的是探讨中国和高加索AM患者的患者特征和生存差异。方法:回顾性分析复旦大学上海肿瘤中心(FUSCC)和梅奥诊所(Mayo Clinic enterprise) 2009 - 2015年两个大型机构黑色素瘤数据库。收集两组患者的临床病理及生存资料进行分析。主要终点是疾病特异性生存(DSS),使用Kaplan Meier (KM)方法计算。结果:与白种人相比,中国组表现出更晚期的疾病:brreslow深度更厚(中位3.0 mm vs. 1.2 mm, p=0.003),溃疡性疾病更多(66.1% vs. 29%;p < 0.001)和晚期(II/III期84.3% vs. 37.1%;P < 0.001)。在诊断年龄、部位、组织学亚型或淋巴结阳性率方面无显著差异。中国和高加索AM患者的5年DSS分别为68.4%和73% (p=0.56)。在多变量分析中,男性、乳腺厚度、溃疡和前哨淋巴结阳性是独立的不良预后因素。结论:中国人和白种人之间的分期生存率似乎没有差异,支持对中国和白种人患者进行AM临床试验的实施。
{"title":"Comparative Analysis of Acral Melanoma in Chinese and Caucasian Patients.","authors":"Kai Huang,&nbsp;Yu Xu,&nbsp;Emmanuel M Gabriel,&nbsp;Subhasis Misra,&nbsp;Yong Chen,&nbsp;Sanjay P Bagaria","doi":"10.1155/2020/5169051","DOIUrl":"https://doi.org/10.1155/2020/5169051","url":null,"abstract":"<p><strong>Background: </strong>Acral melanoma (AM) is a rare subtype of melanoma, which is one of the least common in Caucasian patients but is a common subtype of melanoma in Chinese patients. It is unclear if prognosis differs between Chinese and Caucasian patients diagnosed with AM. The aim of our study is to investigate patient characteristics and survival differences between Chinese and Caucasian AM patients.</p><p><strong>Methods: </strong>Two large institutional melanoma databases from Fudan University Shanghai Cancer Center (FUSCC) and Mayo Clinic enterprise were retrospectively reviewed from 2009 to 2015. Clinicopathologic and survival data were collected and analyzed between the two groups. The primary outcome was disease-specific survival (DSS) and was calculated using the Kaplan Meier (KM) method.</p><p><strong>Results: </strong>The Chinese group presented with more advanced disease compared with Caucasians: thicker Breslow depth (median 3.0 mm vs. 1.2 mm, <i>p</i>=0.003), more ulcerated disease (66.1% vs. 29%; <i>p</i> < 0.001), and advanced stages (stage II/III 84.3% vs. 37.1%; <i>p</i> < 0.001). No significant difference was identified in terms of age at diagnosis, location, histologic subtypes, or node positive rate. The 5-year DSS rate was 68.4% and 73% (<i>p</i>=0.56) in Chinese and Caucasians AM patients, respectively. Male gender, Breslow thickness, ulceration, and positive sentinel lymph nodes were independent poor prognostic factors on multivariate analysis.</p><p><strong>Conclusions: </strong>There appears to be no difference in stage-stratified survival between Chinese and Caucasians, supporting the implementation of clinical trials for AM that could include both Chinese and Caucasian patients.</p>","PeriodicalId":17172,"journal":{"name":"Journal of Skin Cancer","volume":"2020 ","pages":"5169051"},"PeriodicalIF":1.1,"publicationDate":"2020-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/5169051","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38510945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 8
A Histopathological Study of Skin Lesions in Individuals with Oculocutaneous Albinism in Togo in 2019. 2019年多哥皮肤白化病患者皮肤病变的组织病理学研究
IF 1.1 Q3 DERMATOLOGY Pub Date : 2020-07-29 eCollection Date: 2020-01-01 DOI: 10.1155/2020/2361957
Bayaki Saka, Julienne Noude Teclessou, Sefako Abla Akakpo, Piham Gnossike, Kwamé Doh, Saliou Adam, Abas Mouhari-Toure, Garba Mahamadou, Panawé Kassang, Yvette Elegbede Moise, Tchin Darre, Koussake Kombate, Palokinam Pitché

Objective: The aim of this study was to study the histopathological patterns of skin lesions in persons with albinism (PWA) in Togo in 2019.

Method: During two mobile skin care clinics in 2019, biopsies/excisional biopsies were performed in PWA in case of clinical doubt or in front of lesions suspected to be cancerous for histological examination. Anatomopathological reports were thus analysed.

Results: During the two mobile skin care clinics, 115 biopsies/excisional biopsies were carried out in 79 PWA, with a mean age of 24 ± 16.1 years. Histological examination led to a diagnosis in 110 cases (95.6%) and was inconclusive in 5 cases (4 cases of uncertain histological diagnosis and one case of nonspecific histological lesions). Fourteen different histological diagnoses were made, with a frequency ranging from 0.9% (one case) to 26.9% (31 cases). The four most frequent diagnoses in descending order were basal cell carcinomas (BCCs) (31 cases; 26.9%), invasive squamous cell carcinomas (SCCs) or Bowen's disease (23 cases; 20%), keratosis (20 cases; 17.3%), and cysts (seven cases; 6.1%). The 54 skin carcinomas were diagnosed in 33 (41.8%) of the 79 patients who underwent skin biopsies/excisional biopsies. The BCC/SCC ratio was 1.3. No cases of cutaneous melanoma had been diagnosed.

Conclusion: Skin cancers represent the main histological diagnosis in PWA (46.9%) in Togo in 2019. The pattern of cutaneous malignancies in PWA shows the same trend as that seen in Caucasians with a predominance of basal cell carcinomas.

目的:本研究的目的是研究2019年多哥白化病(PWA)患者皮肤病变的组织病理学模式。方法:2019年2个流动皮肤护理诊所,在临床疑点或疑似癌变病灶前行PWA活检/切除活检,进行组织学检查。解剖病理报告因此被分析。结果:在两个流动皮肤护理诊所中,79例PWA共进行活检/切除活检115例,平均年龄24±16.1岁。组织学诊断110例(95.6%),不确定5例(组织学诊断不确定4例,非特异性组织学病变1例)。14种不同的组织学诊断,频率从0.9%(1例)到26.9%(31例)不等。最常见的4种诊断依次为基底细胞癌(基底细胞癌)(31例;26.9%),浸润性鳞状细胞癌(SCCs)或Bowen病(23例;20%),角化病(20例;17.3%),囊肿(7例;6.1%)。79例接受皮肤活检/切除活检的患者中,有33例(41.8%)被诊断为54例皮肤癌。BCC/SCC比值为1.3。未发现皮肤黑色素瘤病例。结论:2019年多哥地区PWA的主要组织学诊断为皮肤癌(46.9%)。PWA皮肤恶性肿瘤的模式与高加索人的趋势相同,以基底细胞癌为主。
{"title":"A Histopathological Study of Skin Lesions in Individuals with Oculocutaneous Albinism in Togo in 2019.","authors":"Bayaki Saka,&nbsp;Julienne Noude Teclessou,&nbsp;Sefako Abla Akakpo,&nbsp;Piham Gnossike,&nbsp;Kwamé Doh,&nbsp;Saliou Adam,&nbsp;Abas Mouhari-Toure,&nbsp;Garba Mahamadou,&nbsp;Panawé Kassang,&nbsp;Yvette Elegbede Moise,&nbsp;Tchin Darre,&nbsp;Koussake Kombate,&nbsp;Palokinam Pitché","doi":"10.1155/2020/2361957","DOIUrl":"https://doi.org/10.1155/2020/2361957","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to study the histopathological patterns of skin lesions in persons with albinism (PWA) in Togo in 2019.</p><p><strong>Method: </strong>During two mobile skin care clinics in 2019, biopsies/excisional biopsies were performed in PWA in case of clinical doubt or in front of lesions suspected to be cancerous for histological examination. Anatomopathological reports were thus analysed.</p><p><strong>Results: </strong>During the two mobile skin care clinics, 115 biopsies/excisional biopsies were carried out in 79 PWA, with a mean age of 24 ± 16.1 years. Histological examination led to a diagnosis in 110 cases (95.6%) and was inconclusive in 5 cases (4 cases of uncertain histological diagnosis and one case of nonspecific histological lesions). Fourteen different histological diagnoses were made, with a frequency ranging from 0.9% (one case) to 26.9% (31 cases). The four most frequent diagnoses in descending order were basal cell carcinomas (BCCs) (31 cases; 26.9%), invasive squamous cell carcinomas (SCCs) or Bowen's disease (23 cases; 20%), keratosis (20 cases; 17.3%), and cysts (seven cases; 6.1%). The 54 skin carcinomas were diagnosed in 33 (41.8%) of the 79 patients who underwent skin biopsies/excisional biopsies. The BCC/SCC ratio was 1.3. No cases of cutaneous melanoma had been diagnosed.</p><p><strong>Conclusion: </strong>Skin cancers represent the main histological diagnosis in PWA (46.9%) in Togo in 2019. The pattern of cutaneous malignancies in PWA shows the same trend as that seen in Caucasians with a predominance of basal cell carcinomas.</p>","PeriodicalId":17172,"journal":{"name":"Journal of Skin Cancer","volume":"2020 ","pages":"2361957"},"PeriodicalIF":1.1,"publicationDate":"2020-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/2361957","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38268451","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
SunSmart Accreditation and Use of a Professional Policy Drafting Service: Both Positively and Independently Associated with High Sun Protective Hat Scores Derived from Primary School Policies. SunSmart认证和专业政策起草服务的使用:与小学政策获得的高防晒帽分数有积极和独立的关系。
IF 1.1 Q3 DERMATOLOGY Pub Date : 2020-06-30 eCollection Date: 2020-01-01 DOI: 10.1155/2020/9695080
A I Reeder, E E Iosua, B McNoe, A-C L Petersen

Background: The head and neck are exposed to the highest solar ultraviolet radiation levels and experience a disproportionate skin cancer burden. Sun protective hats can provide an effective barrier. Since early life exposure contributes to skin cancer risk, the World Health Organisation recommends prevention programmes in schools. The New Zealand SunSmart Schools programme is one example. Two criteria concern wearing hat outdoors: students are required to wear a hat providing protection for the face, neck, and ears; if a suitable hat is not worn, students must play in shaded areas.

Objectives: To investigate two internationally relevant interventions as plausible statistical predictors of hat policy strength: (1) skin cancer primary prevention programme membership, (2) use of a professional policy drafting service.

Methods: Of 1,242 (62%) eligible schools participating in a 2017 national survey, 1,137 reported a sun protection policy and 842 were available for categorising and allocating protective scores (0-3).

Results: In multinomial (polytomous) logistic regression models of cross-sectional association, adjusted for school characteristics, SunSmart accredited schools and those utilising a policy drafting service were independently significantly more likely than their counterparts to obtain the most protective compared to the least protective hat score (respectively, RRR 6.48: 95% CI 3.66, 11.47; 7.47: 3.67, and 15.20). For the dichotomous shade measure, similar associations were found using adjusted logistic regression (OR 3.28: 95% CI 2.11, 5.09; 2.70: 1.54, 4.74).

Conclusions: Our findings provide support for two plausible interventions that could potentially be implemented beneficially in primary schools via established infrastructure in any jurisdiction, internationally.

背景:头部和颈部暴露于最高的太阳紫外线辐射水平,并经历不成比例的皮肤癌负担。遮阳帽可以提供有效的屏障。由于生命早期接触会增加患皮肤癌的风险,世界卫生组织建议在学校开展预防项目。新西兰SunSmart学校项目就是一个例子。在户外戴帽子有两个标准:学生必须戴上帽子,以保护面部、颈部和耳朵;如果没有戴合适的帽子,学生必须在阴凉的地方玩耍。目的:研究两种国际上相关的干预措施作为政策强度的可信统计预测因素:(1)皮肤癌初级预防计划的成员资格,(2)专业政策起草服务的使用。方法:在参与2017年全国调查的1242所(62%)符合条件的学校中,1137所报告了防晒政策,842所可用于分类和分配防晒评分(0-3)。结果:在针对学校特征进行调整的横截面关联的多项(多分式)逻辑回归模型中,SunSmart认证的学校和使用政策起草服务的学校获得最具保护性的帽子得分的可能性显著高于获得最不具保护性帽子得分的可能性(分别为RRR 6.48: 95% CI 3.66, 11.47;7.47: 3.67和15.20)。对于二分荫蔽测量,使用调整后的逻辑回归发现了类似的关联(OR 3.28: 95% CI 2.11, 5.09;2.70: 1.54, 4.74)。结论:我们的研究结果为两种可行的干预措施提供了支持,这两种干预措施可以通过国际上任何司法管辖区的既定基础设施在小学中实施。
{"title":"SunSmart Accreditation and Use of a Professional Policy Drafting Service: Both Positively and Independently Associated with High Sun Protective Hat Scores Derived from Primary School Policies.","authors":"A I Reeder,&nbsp;E E Iosua,&nbsp;B McNoe,&nbsp;A-C L Petersen","doi":"10.1155/2020/9695080","DOIUrl":"https://doi.org/10.1155/2020/9695080","url":null,"abstract":"<p><strong>Background: </strong>The head and neck are exposed to the highest solar ultraviolet radiation levels and experience a disproportionate skin cancer burden. Sun protective hats can provide an effective barrier. Since early life exposure contributes to skin cancer risk, the World Health Organisation recommends prevention programmes in schools. The New Zealand SunSmart Schools programme is one example. Two criteria concern wearing hat outdoors: students are required to wear a hat providing protection for the face, neck, and ears; if a suitable hat is not worn, students must play in shaded areas.</p><p><strong>Objectives: </strong>To investigate two internationally relevant interventions as plausible statistical predictors of hat policy strength: (1) skin cancer primary prevention programme membership, (2) use of a professional policy drafting service.</p><p><strong>Methods: </strong>Of 1,242 (62%) eligible schools participating in a 2017 national survey, 1,137 reported a sun protection policy and 842 were available for categorising and allocating protective scores (0-3).</p><p><strong>Results: </strong>In multinomial (polytomous) logistic regression models of cross-sectional association, adjusted for school characteristics, SunSmart accredited schools and those utilising a policy drafting service were independently significantly more likely than their counterparts to obtain the most protective compared to the least protective hat score (respectively, RRR 6.48: 95% CI 3.66, 11.47; 7.47: 3.67, and 15.20). For the dichotomous shade measure, similar associations were found using adjusted logistic regression (OR 3.28: 95% CI 2.11, 5.09; 2.70: 1.54, 4.74).</p><p><strong>Conclusions: </strong>Our findings provide support for two plausible interventions that could potentially be implemented beneficially in primary schools via established infrastructure in any jurisdiction, internationally.</p>","PeriodicalId":17172,"journal":{"name":"Journal of Skin Cancer","volume":"2020 ","pages":"9695080"},"PeriodicalIF":1.1,"publicationDate":"2020-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1155/2020/9695080","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"38160553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Skin Cancer
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1